Sotera Health upgraded by JP Morgan with a new price target
$SHC
Misc Health and Biotechnology Services
Health Care
JP Morgan upgraded Sotera Health from Underweight to Neutral and set a new price target of $18.00 from $6.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/5/2025 | $17.00 | Neutral → Buy | Goldman |
| 12/6/2024 | $14.00 | Neutral | Goldman |
| 5/21/2024 | $13.00 | Neutral | Piper Sandler |
| 4/3/2024 | $18.00 → $16.00 | Neutral → Buy | Citigroup |
| 3/25/2024 | $15.00 → $15.50 | Hold → Buy | Jefferies |
| 2/6/2024 | Sector Weight | KeyBanc Capital Markets | |
| 6/26/2023 | $24.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 1/23/2023 | $6.00 → $18.00 | Underweight → Neutral | JP Morgan |